Where can I learn more about this study?
You can find more information about this study on the websites listed below. If
more information about the study results is available, it can also be found here.
> www.clinicaltrials.gov. Once you are on the website, type “NCT03615924”
into the search box and click “Search”.
www.clinicaltrialsregister.eu. Once you are on the website, click
>
“Home and Search”, then type “2017-002421-38” in the search
box and click “Search”.
www.AstraZenecaClinicalTrials.com. Once you are on the website, type
>
“D5136C00009” into the search box, and click “Find a Study”.
> Full Study Title: A Randomized, Double-Blind, Parallel-Group,
Multicentre, Phase III Study to Evaluate the Effect of Ticagrelor versus
Placebo in Reducing the Rate of Vaso-Occlusive Crises in Pediatric Patients
with Sickle Cell Disease (HESTIA3)
AstraZeneca AB Protocol Number: D5136C00009
National Clinical Trials Number: NCT03615924
EudraCT Number: 2017-002421-38
AstraZeneca AB sponsored this study and has its headquarters in Cambridge, UK.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you
Clinical study participants and their families belong to a large community of
people who take part in clinical research around the world. They help researchers
answer important health questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused on
educating and informing the public about clinical research participation. CISCRP is not involved in recruiting participants
for clinical studies, nor is it involved in conducting clinical studies.
CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org
Version 1.0 2021_02_01
12 | Clinical Study Results